Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1994 Jun;144(6):1172–1182.

Differential expression of beta 1 integrins in nonneoplastic smooth and striated muscle cells and in tumors derived from these cells.

G Mechtersheimer 1, T Barth 1, A Quentmeier 1, P Möller 1
PMCID: PMC1887445  PMID: 7515557

Abstract

Integrins are a superfamily of transmembrane alpha beta heterodimers that play an important role in cell-matrix and cell-cell interactions by acting as receptors for extracellular matrix proteins and for cell adhesion molecules. Using monoclonal antibodies against beta 1, alpha 1 to alpha 6, and alpha v subunits, the in situ distribution pattern of beta 1 integrins was examined immunohistochemically in nonneoplastic smooth and striated muscle cells and in their tumors. Nonneoplastic smooth muscle cells were beta 1+, alpha 1+, alpha 3+, alpha v+ and, in diverse localizations, also alpha 5+ or even alpha 6+. The expression of the beta 1 chain was conserved in all leiomyomas and leiomyosarcomas. The distribution pattern of the alpha subunits by contrast underwent several changes during malignant transformation of smooth muscle cells. These alterations consisted in a neoexpression of alpha 2, alpha 4, and alpha 6 as well as in an abnormal abrogation of alpha 1 and alpha 3 in some leiomyosarcomas. Except for the absence of alpha 5 in the majority of epithelioid leiomyosarcomas, expression of the alpha 5 and alpha v subunits was mainly conserved. In addition, tumors with epithelioid differentiation differed from typical cases by the absence of alpha 1 and the simultaneous presence of alpha 4. Adult striated muscle cells were beta 1+ but alpha 1- to alpha 6- and alpha v-, whereas fetal striated muscle cells were not only beta 1+ but also alpha 3+/-, alpha 4+/-, alpha 5+ and alpha 6+. In all rhabdomyosarcomas the expression of beta 1 was retained. Furthermore, the majority of cases showed the expression of one or more alpha subunits most of which, ie, alpha 4, alpha 5, and alpha 6, were also found in fetal striated muscle cells. In conclusion, beta 1 integrins exhibited a differential expression pattern along the two lines of myogenic differentiation. This integrin profile underwent characteristic changes during malignant transformation. Nevertheless, the compiled distribution patterns of the alpha 1, alpha 3, and alpha v subunits allowed in most instances the discrimination between tumors of smooth (alpha 1+/alpha 3+/alpha v+) and striated muscle (alpha 1-/alpha 3-/alpha v-) differentiation.

Full text

PDF
1172

Images in this article

1176Figure 1
on p.1176
1176Figure 2
on p.1176
1177Figure 3
on p.1177
1178Figure 4
on p.1178
1178Figure 5
on p.1178

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albelda S. M., Mette S. A., Elder D. E., Stewart R., Damjanovich L., Herlyn M., Buck C. A. Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. Cancer Res. 1990 Oct 15;50(20):6757–6764. [PubMed] [Google Scholar]
  2. Amiot M., Bernard A., Tran H. C., Leca G., Kanellopoulos J. M., Boumsell L. The human cell surface glycoprotein complex (gp 120,200) recognized by monoclonal antibody K20 is a component binding to phytohaemagglutinin on T cells. Scand J Immunol. 1986 Jan;23(1):109–118. doi: 10.1111/j.1365-3083.1986.tb01948.x. [DOI] [PubMed] [Google Scholar]
  3. Bodary S. C., McLean J. W. The integrin beta 1 subunit associates with the vitronectin receptor alpha v subunit to form a novel vitronectin receptor in a human embryonic kidney cell line. J Biol Chem. 1990 Apr 15;265(11):5938–5941. [PubMed] [Google Scholar]
  4. Chan B. M., Matsuura N., Takada Y., Zetter B. R., Hemler M. E. In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. Science. 1991 Mar 29;251(5001):1600–1602. doi: 10.1126/science.2011740. [DOI] [PubMed] [Google Scholar]
  5. Collo G., Starr L., Quaranta V. A new isoform of the laminin receptor integrin alpha 7 beta 1 is developmentally regulated in skeletal muscle. J Biol Chem. 1993 Sep 5;268(25):19019–19024. [PubMed] [Google Scholar]
  6. Covault J., Merlie J. P., Goridis C., Sanes J. R. Molecular forms of N-CAM and its RNA in developing and denervated skeletal muscle. J Cell Biol. 1986 Mar;102(3):731–739. doi: 10.1083/jcb.102.3.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dedhar S., Jewell K., Rojiani M., Gray V. The receptor for the basement membrane glycoprotein entactin is the integrin alpha 3/beta 1. J Biol Chem. 1992 Sep 15;267(26):18908–18914. [PubMed] [Google Scholar]
  8. Defilippi P., Truffa G., Stefanuto G., Altruda F., Silengo L., Tarone G. Tumor necrosis factor alpha and interferon gamma modulate the expression of the vitronectin receptor (integrin beta 3) in human endothelial cells. J Biol Chem. 1991 Apr 25;266(12):7638–7645. [PubMed] [Google Scholar]
  9. Elices M. J., Osborn L., Takada Y., Crouse C., Luhowskyj S., Hemler M. E., Lobb R. R. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell. 1990 Feb 23;60(4):577–584. doi: 10.1016/0092-8674(90)90661-w. [DOI] [PubMed] [Google Scholar]
  10. Enomoto M. I., Boettiger D., Menko A. S. Alpha 5 integrin is a critical component of adhesion plaques in myogenesis. Dev Biol. 1993 Jan;155(1):180–197. doi: 10.1006/dbio.1993.1017. [DOI] [PubMed] [Google Scholar]
  11. Favrot M. C., Combaret V., Goillot E., Lutz P., Frappaz D., Thiesse P., Thyss A., Dolbeau D., Bouffet E., Tabone E. Expression of integrin receptors on 45 clinical neuroblastoma specimens. Int J Cancer. 1991 Sep 30;49(3):347–355. doi: 10.1002/ijc.2910490306. [DOI] [PubMed] [Google Scholar]
  12. Fingerman E., Hemler M. E. Regulation of proteins in the VLA cell substrate adhesion family: influence of cell growth conditions on VLA-1, VLA-2, and VLA-3 expression. Exp Cell Res. 1988 Jul;177(1):132–142. doi: 10.1016/0014-4827(88)90031-6. [DOI] [PubMed] [Google Scholar]
  13. Fradet Y., Cordon-Cardo C., Thomson T., Daly M. E., Whitmore W. F., Jr, Lloyd K. O., Melamed M. R., Old L. J. Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies. Proc Natl Acad Sci U S A. 1984 Jan;81(1):224–228. doi: 10.1073/pnas.81.1.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Giltay J. C., Brinkman H. J., Modderman P. W., von dem Borne A. E., van Mourik J. A. Human vascular endothelial cells express a membrane protein complex immunochemically indistinguishable from the platelet VLA-2 (glycoprotein Ia-IIa) complex. Blood. 1989 Apr;73(5):1235–1241. [PubMed] [Google Scholar]
  15. Heino J., Ignotz R. A., Hemler M. E., Crouse C., Massagué J. Regulation of cell adhesion receptors by transforming growth factor-beta. Concomitant regulation of integrins that share a common beta 1 subunit. J Biol Chem. 1989 Jan 5;264(1):380–388. [PubMed] [Google Scholar]
  16. Hemler M. E., Jacobson J. G., Brenner M. B., Mann D., Strominger J. L. VLA-1: a T cell surface antigen which defines a novel late stage of human T cell activation. Eur J Immunol. 1985 May;15(5):502–508. doi: 10.1002/eji.1830150515. [DOI] [PubMed] [Google Scholar]
  17. Hemler M. E., Jacobson J. G. Cell matrix adhesion-related proteins VLA-1 and VLA-2: regulation of expression on T cells. J Immunol. 1987 May 1;138(9):2941–2948. [PubMed] [Google Scholar]
  18. Hemler M. E., Sanchez-Madrid F., Flotte T. J., Krensky A. M., Burakoff S. J., Bhan A. K., Springer T. A., Strominger J. L. Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines. J Immunol. 1984 Jun;132(6):3011–3018. [PubMed] [Google Scholar]
  19. Hemler M. E. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol. 1990;8:365–400. doi: 10.1146/annurev.iy.08.040190.002053. [DOI] [PubMed] [Google Scholar]
  20. Hsiao L. L., Peltonen J., Jaakkola S., Gralnick H., Uitto J. Plasticity of integrin expression by nerve-derived connective tissue cells. Human Schwann cells, perineurial cells, and fibroblasts express markedly different patterns of beta 1 integrins during nerve development, neoplasia, and in vitro. J Clin Invest. 1991 Mar;87(3):811–820. doi: 10.1172/JCI115084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hynes R. O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992 Apr 3;69(1):11–25. doi: 10.1016/0092-8674(92)90115-s. [DOI] [PubMed] [Google Scholar]
  22. Kadagidze Z. G., Tupitsyn N. N., Baryshnikov A. J., Kadyrov K. P., Blinov V. M., Bernard A., Amiot M., Boumsell L. K20 and ICO-10 monoclonal antibodies (gp120/200; Thy-1): immunophenotyping of human solid tumours. Br J Cancer. 1990 Feb;61(2):215–217. doi: 10.1038/bjc.1990.39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kirchhofer D., Languino L. R., Ruoslahti E., Pierschbacher M. D. Alpha 2 beta 1 integrins from different cell types show different binding specificities. J Biol Chem. 1990 Jan 15;265(2):615–618. [PubMed] [Google Scholar]
  24. Klein C. E., Steinmayer T., Kaufmann D., Weber L., Bröcker E. B. Identification of a melanoma progression antigen as integrin VLA-2. J Invest Dermatol. 1991 Feb;96(2):281–284. doi: 10.1111/1523-1747.ep12464485. [DOI] [PubMed] [Google Scholar]
  25. Korhonen M., Laitinen L., Ylänne J., Koukoulis G. K., Quaranta V., Juusela H., Gould V. E., Virtanen I. Integrin distributions in renal cell carcinomas of various grades of malignancy. Am J Pathol. 1992 Nov;141(5):1161–1171. [PMC free article] [PubMed] [Google Scholar]
  26. Koukoulis G. K., Virtanen I., Korhonen M., Laitinen L., Quaranta V., Gould V. E. Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Correlations with their functions as receptors and cell adhesion molecules. Am J Pathol. 1991 Oct;139(4):787–799. [PMC free article] [PubMed] [Google Scholar]
  27. Kramer R. H., McDonald K. A., Vu M. P. Human melanoma cells express a novel integrin receptor for laminin. J Biol Chem. 1989 Sep 15;264(26):15642–15649. [PubMed] [Google Scholar]
  28. Lakonishok M., Muschler J., Horwitz A. F. The alpha 5 beta 1 integrin associates with a dystrophin-containing lattice during muscle development. Dev Biol. 1992 Aug;152(2):209–220. doi: 10.1016/0012-1606(92)90129-5. [DOI] [PubMed] [Google Scholar]
  29. Lopes M. T., Sonohara S., Chammas R., Brentani M. M. Effects of steroids on laminin-binding integrins in a human melanoma cell line. Int J Cancer. 1991 Apr 22;48(1):73–80. doi: 10.1002/ijc.2910480114. [DOI] [PubMed] [Google Scholar]
  30. MacCalman C. D., Bardeesy N., Holland P. C., Blaschuk O. W. Noncoordinate developmental regulation of N-cadherin, N-CAM, integrin, and fibronectin mRNA levels during myoblast terminal differentiation. Dev Dyn. 1992 Oct;195(2):127–132. doi: 10.1002/aja.1001950207. [DOI] [PubMed] [Google Scholar]
  31. Martìn-Padura I., Mortarini R., Lauri D., Bernasconi S., Sanchez-Madrid F., Parmiani G., Mantovani A., Anichini A., Dejana E. Heterogeneity in human melanoma cell adhesion to cytokine activated endothelial cells correlates with VLA-4 expression. Cancer Res. 1991 Apr 15;51(8):2239–2241. [PubMed] [Google Scholar]
  32. Mattila P., Majuri M. L., Renkonen R. VLA-4 integrin on sarcoma cell lines recognizes endothelial VCAM-1. Differential regulation of the VLA-4 avidity on various sarcoma cell lines. Int J Cancer. 1992 Dec 2;52(6):918–923. doi: 10.1002/ijc.2910520615. [DOI] [PubMed] [Google Scholar]
  33. Mechtersheimer G., Munk M., Barth T., Koretz K., Möller P. Expression of beta 1 integrins in non-neoplastic mammary epithelium, fibroadenoma and carcinoma of the breast. Virchows Arch A Pathol Anat Histopathol. 1993;422(3):203–210. doi: 10.1007/BF01621803. [DOI] [PubMed] [Google Scholar]
  34. Mechtersheimer G., Staudter M., Möller P. Expression of the natural killer cell-associated antigens CD56 and CD57 in human neural and striated muscle cells and in their tumors. Cancer Res. 1991 Feb 15;51(4):1300–1307. [PubMed] [Google Scholar]
  35. Mechtersheimer G. Towards the phenotyping of soft tissue tumours by cell surface molecules. Virchows Arch A Pathol Anat Histopathol. 1991;419(1):7–28. doi: 10.1007/BF01600148. [DOI] [PubMed] [Google Scholar]
  36. Miettinen M., Castello R., Wayner E., Schwarting R. Distribution of VLA integrins in solid tumors. Emergence of tumor-type-related expression. Patterns in carcinomas and sarcomas. Am J Pathol. 1993 Apr;142(4):1009–1018. [PMC free article] [PubMed] [Google Scholar]
  38. Pecoraro G., Lee M., Morgan D., Defendi V. Evolution of in vitro transformation and tumorigenesis of HPV16 and HPV18 immortalized primary cervical epithelial cells. Am J Pathol. 1991 Jan;138(1):1–8. [PMC free article] [PubMed] [Google Scholar]
  39. Peltonen J., Larjava H., Jaakkola S., Gralnick H., Akiyama S. K., Yamada S. S., Yamada K. M., Uitto J. Localization of integrin receptors for fibronectin, collagen, and laminin in human skin. Variable expression in basal and squamous cell carcinomas. J Clin Invest. 1989 Dec;84(6):1916–1923. doi: 10.1172/JCI114379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Pignatelli M., Smith M. E., Bodmer W. F. Low expression of collagen receptors in moderate and poorly differentiated colorectal adenocarcinomas. Br J Cancer. 1990 Apr;61(4):636–638. doi: 10.1038/bjc.1990.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Pytela R., Pierschbacher M. D., Ruoslahti E. Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor. Cell. 1985 Jan;40(1):191–198. doi: 10.1016/0092-8674(85)90322-8. [DOI] [PubMed] [Google Scholar]
  42. Rosen G. D., Sanes J. R., LaChance R., Cunningham J. M., Roman J., Dean D. C. Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis. Cell. 1992 Jun 26;69(7):1107–1119. doi: 10.1016/0092-8674(92)90633-n. [DOI] [PubMed] [Google Scholar]
  43. Ruoslahti E., Pierschbacher M. D. New perspectives in cell adhesion: RGD and integrins. Science. 1987 Oct 23;238(4826):491–497. doi: 10.1126/science.2821619. [DOI] [PubMed] [Google Scholar]
  44. Schlossman S. F., Boumsell L., Gilks W., Harlan J. M., Kishimoto T., Morimoto C., Ritz J., Shaw S., Silverstein R. L., Springer T. A. CD antigens 1993. J Immunol. 1994 Jan 1;152(1):1–2. [PubMed] [Google Scholar]
  45. Song W. K., Wang W., Foster R. F., Bielser D. A., Kaufman S. J. H36-alpha 7 is a novel integrin alpha chain that is developmentally regulated during skeletal myogenesis. J Cell Biol. 1992 May;117(3):643–657. doi: 10.1083/jcb.117.3.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Sonnenberg A., Janssen H., Hogervorst F., Calafat J., Hilgers J. A complex of platelet glycoproteins Ic and IIa identified by a rat monoclonal antibody. J Biol Chem. 1987 Jul 25;262(21):10376–10383. [PubMed] [Google Scholar]
  47. Sánchez-Madrid F., De Landázuri M. O., Morago G., Cebrián M., Acevedo A., Bernabeu C. VLA-3: a novel polypeptide association within the VLA molecular complex: cell distribution and biochemical characterization. Eur J Immunol. 1986 Nov;16(11):1343–1349. doi: 10.1002/eji.1830161106. [DOI] [PubMed] [Google Scholar]
  48. Vogel B. E., Tarone G., Giancotti F. G., Gailit J., Ruoslahti E. A novel fibronectin receptor with an unexpected subunit composition (alpha v beta 1). J Biol Chem. 1990 Apr 15;265(11):5934–5937. [PubMed] [Google Scholar]
  49. Wayner E. A., Garcia-Pardo A., Humphries M. J., McDonald J. A., Carter W. G. Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J Cell Biol. 1989 Sep;109(3):1321–1330. doi: 10.1083/jcb.109.3.1321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Zutter M. M., Mazoujian G., Santoro S. A. Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast. Am J Pathol. 1990 Oct;137(4):863–870. [PMC free article] [PubMed] [Google Scholar]
  51. Zylstra S., Chen F. A., Ghosh S. K., Repasky E. A., Rao U., Takita H., Bankert R. B. Membrane-associated glycoprotein (gp 160) identified on human lung tumors by a monoclonal antibody. Cancer Res. 1986 Dec;46(12 Pt 1):6446–6451. [PubMed] [Google Scholar]
  52. de Vries J. E., Keizer G. D., te Velde A. A., Voordouw A., Ruiter D., Rümke P., Spits H., Figdor C. G. Characterization of melanoma-associated surface antigens involved in the adhesion and motility of human melanoma cells. Int J Cancer. 1986 Oct 15;38(4):465–473. doi: 10.1002/ijc.2910380403. [DOI] [PubMed] [Google Scholar]
  53. te Velde A. A., Klomp J. P., Yard B. A., de Vries J. E., Figdor C. G. Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4. J Immunol. 1988 Mar 1;140(5):1548–1554. [PubMed] [Google Scholar]
  54. von der Mark H., Dürr J., Sonnenberg A., von der Mark K., Deutzmann R., Goodman S. L. Skeletal myoblasts utilize a novel beta 1-series integrin and not alpha 6 beta 1 for binding to the E8 and T8 fragments of laminin. J Biol Chem. 1991 Dec 15;266(35):23593–23601. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES